• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Connect Biopharma Holdings Limited - Ordinary Shares (NQ:CNTB)

    0.9655 -0.1345 (-12.23%)
    Delayed Quote Updated: 3:30 PM EDT, Oct 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 7,539,236
    Open 1.115
    Bid (Size) 0.9651 (18,800)
    Ask (Size) 0.9658 (400)
    Prev. Close 1.100
    Today's Range 0.9433 - 1.120
    52wk Range 0.9800 - 3.820
    Shares Outstanding 55,041,247
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Top movers analysis one hour before the close of the markets on 2026-09-30: top gainers and losers in today's session. ↗
    Via Chartmill
    Discover the most active stocks in Wednesday's session. ↗
    Via Chartmill

    Performance

    YTD
    -61.7%
    -61.7%
    1 Month
    -56.1%
    -56.1%
    3 Month
    -59.6%
    -59.6%
    6 Month
    -64.5%
    -64.5%
    1 Year
    -36.1%
    -36.1%

    More News

    Read More
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    Which stocks are gapping on Wednesday? ↗
    Via Chartmill
    Wednesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Tuesday's session. ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026 ↗
    Via MarketBeat
    News headline image
    Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
    Via ACCESS Newswire
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Announces $20.2 Million Private Placement Financing
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire
    News headline image
    Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
    From Connect Biopharma Holdings Limited
    Via GlobeNewswire

    Frequently Asked Questions

    Is Connect Biopharma Holdings Limited - Ordinary Shares publicly traded?
    Yes, Connect Biopharma Holdings Limited - Ordinary Shares is publicly traded.
    What exchange does Connect Biopharma Holdings Limited - Ordinary Shares trade on?
    Connect Biopharma Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Connect Biopharma Holdings Limited - Ordinary Shares?
    The ticker symbol for Connect Biopharma Holdings Limited - Ordinary Shares is CNTB on the Nasdaq Stock Market
    What is the current price of Connect Biopharma Holdings Limited - Ordinary Shares?
    The current price of Connect Biopharma Holdings Limited - Ordinary Shares is 0.9655
    When was Connect Biopharma Holdings Limited - Ordinary Shares last traded?
    The last trade of Connect Biopharma Holdings Limited - Ordinary Shares was at 10/01/26 03:30 PM ET
    What is the market capitalization of Connect Biopharma Holdings Limited - Ordinary Shares?
    The market capitalization of Connect Biopharma Holdings Limited - Ordinary Shares is 53.14M
    How many shares of Connect Biopharma Holdings Limited - Ordinary Shares are outstanding?
    Connect Biopharma Holdings Limited - Ordinary Shares has 53M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.